×
Back to Agenda
Session 2: Bridge from Evaluation to Access through Collaboration with Payers
Session Chair(s)
Virginia Acha, PHD, MSC
Global Lead, Global Regulatory Policy, Merck & Co., Inc., United States
Session 2: Bridge from Evaluation to Access through Collaboration with Payers
Speaker(s)
Ansgar Hebborn, PHD, MBA
Head - Access Policy Affairs Europe, F. Hoffmann-La Roche AG, Switzerland
Michael Berntgen, PHD
Head of Scientific Evidence Generation, European Medicines Agency, Netherlands
Work Towards Addressing the Evidence Gap
Evert Jan van Lente, MS
Director EU-Affairs, AOK Bundesverband (Federal Insurer), Germany
Payer’s Perspective
Have an account?